You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》瑞信上調錦欣生殖(01951.HK)目標價至19元 評級「跑贏大市」
阿思達克 10-21 10:00
瑞信發表研究報告指,錦欣生殖(01951.HK)斥資30億元人民幣購入婦產科及兒科醫療服務公司股權, 與亞太區其他上市的私營醫院運營商市盈率對比,認爲估值合理,預期交易將令業務更多元化。 瑞信同時提到,收購遵循內地當局政府對輔助生殖發展的指導,認爲若果未來行業政策進一步收緊,此次收購將爲錦欣生殖提供更大的靈活性來應對監管環境,相信進入正規的婦產科業務亦屬公司的風險控制方針。 該行將2022至2023財年每股盈利預測上調10.6%及7.6%,維持「跑贏大市」評級,目標價上調至19元(原本18.5元)。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account